Biomind Labs Inc. (BMNDF)
USD 0.7
(150.27%)
USD 0.7
(150.27%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -1.21 Million USD | 59.33% |
| 2022 | -2.98 Million USD | 31.09% |
| 2021 | -4.33 Million USD | -2179.71% |
| 2020 | -190.04 Thousand USD | 47.73% |
| 2019 | -363.59 Thousand USD | 67.96% |
| 2018 | -1.13 Million USD | 69.7% |
| 2017 | -3.74 Million USD | -508.83% |
| 2016 | -615.05 Thousand USD | 55.19% |
| 2015 | -1.37 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -185.32 Thousand USD | 33.71% |
| 2024 Q2 | -212.01 Thousand USD | -14.42% |
| 2023 Q2 | -361.11 Thousand USD | 16.73% |
| 2023 Q3 | -125.61 Thousand USD | 65.22% |
| 2023 Q4 | -279.57 Thousand USD | -122.56% |
| 2023 Q1 | -433.66 Thousand USD | 18.62% |
| 2023 FY | -1.21 Million USD | 59.33% |
| 2022 Q1 | -767.99 Thousand USD | 35.29% |
| 2022 FY | -2.98 Million USD | 31.09% |
| 2022 Q4 | -532.9 Thousand USD | 42.34% |
| 2022 Q3 | -924.15 Thousand USD | -12.96% |
| 2022 Q2 | -818.13 Thousand USD | -6.53% |
| 2021 Q1 | -297.04 Thousand USD | 0.0% |
| 2021 Q4 | -1.18 Million USD | 53.8% |
| 2021 Q2 | -279.51 Thousand USD | 5.9% |
| 2021 Q3 | -2.56 Million USD | -819.05% |
| 2021 FY | -4.33 Million USD | -2179.71% |
| 2020 Q1 | -48.44 Thousand USD | 0.0% |
| 2020 FY | -190.04 Thousand USD | 47.73% |
| 2019 FY | -363.59 Thousand USD | 67.96% |
| 2018 FY | -1.13 Million USD | 69.7% |
| 2017 FY | -3.74 Million USD | -508.83% |
| 2016 FY | -615.05 Thousand USD | 55.19% |
| 2015 FY | -1.37 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | -1.33 Million USD | 9.069% |
| Arch Therapeutics, Inc. | -6.98 Million USD | 82.61% |
| Evofem Biosciences, Inc. | 52.97 Million USD | 102.292% |
| Nascent Biotech, Inc. | -2.08 Million USD | 41.834% |
| Rebus Holdings, Inc. | -1.02 Million USD | -19.051% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 101.864% |
| Qrons Inc. | -789.34 Thousand USD | -53.838% |
| Adynxx, Inc. | - USD | Infinity% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -92.015% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | 98.06% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -192.27% |
| Skye Bioscience, Inc. | -37.64 Million USD | 96.774% |
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | 98.38% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | 81.534% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -344.151% |
| SQZ Biotechnologies Company | -79.46 Million USD | 98.472% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | 58.017% |
| Propanc Biopharma, Inc. | -1.82 Million USD | 33.299% |
| Mesoblast Limited | -87.95 Million USD | 98.619% |
| Marizyme, Inc. | -65.34 Million USD | 98.142% |
| Genus plc | 7.9 Million USD | 115.371% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | 88.851% |
| Pharming Group N.V. | -10.54 Million USD | 88.488% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | 44.036% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | 67.271% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | 86.27% |
| ContraFect Corporation | -65.15 Million USD | 98.136% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | 75.147% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | 29.705% |
| IMV Inc. | -36.48 Million USD | 96.672% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | 84.933% |
| MultiCell Technologies, Inc. | -380.07 USD | -319398.777% |
| ONE Bio Corp. | 8.67 Million USD | 113.995% |
| Accustem Sciences Inc. | -3.74 Million USD | 67.587% |
| RVL Pharmaceuticals plc | -51.69 Million USD | 97.651% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -1.26 Million USD | 4.168% |
| Q BioMed Inc. | -2.05 Million USD | 40.825% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | 67.471% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | 48.997% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | 97.967% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | 60.851% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | 84.635% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | 37.703% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -8008.433% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | 92.349% |
| Curative Biotechnology, Inc. | -5.81 Million USD | 79.126% |
| GB Sciences, Inc. | -1.36 Million USD | 10.822% |
| Alpha Cognition Inc. | -13.77 Million USD | 91.183% |
| HST Global, Inc. | -146.21 Thousand USD | -730.531% |
| CSL Limited | 2.64 Billion USD | 100.046% |
| Wesana Health Holdings Inc. | -1.75 Million USD | 30.799% |
| Halberd Corporation | -79.67 Thousand USD | -1424.071% |
| Enzolytics Inc. | -2.17 Million USD | 44.216% |
| Agentix Corp. | -1.37 Million USD | 11.635% |
| Resverlogix Corp. | -3.61 Million USD | 66.362% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | 61.711% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -295.05 Million USD | 99.588% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 1339.101% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 117.536% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | 69.436% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | 59.872% |
| AVAX Technologies, Inc. | -6.41 Million USD | 81.067% |
| Zenith Capital Corp. | -10.59 Million USD | 88.54% |
| Genscript Biotech Corporation | -95.47 Million USD | 98.728% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -5124.675% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | 70.711% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -1909.111% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | 39.439% |
| Kadimastem Ltd | -3.3 Million USD | 63.285% |
| Helix BioMedix, Inc. | -1.05 Million USD | -14.986% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -3.81 Million USD | 68.203% |
| BioStem Technologies, Inc. | -8.48 Million USD | 85.685% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -175.126% |
| LadRx Corporation | 400.44 Thousand USD | 403.244% |
| Cell Source, Inc. | -5.32 Million USD | 77.18% |
| Regen BioPharma, Inc. | 1.02 Million USD | 218.643% |
| Regen BioPharma, Inc. | 1.02 Million USD | 218.643% |
| NovAccess Global Inc. | -4.76 Million USD | 74.538% |
| Affymax, Inc. | -14.42 Million USD | 91.581% |
| Itoco Inc. | -1.86 Million USD | 35.028% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | 72.666% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | 27.243% |
| Mobile Lads Corp. | -2.26 Million USD | 46.347% |
| CytoDyn Inc. | -49.84 Million USD | 97.564% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -1436.471% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -432.3% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -28.973% |
| SYBLEU INC | -180.3 Thousand USD | -573.484% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | 24.704% |
| International Stem Cell Corporation | -131 Thousand USD | -826.961% |
| Bioxytran, Inc. | -4.28 Million USD | 71.628% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -2137.469% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | 52.008% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | 97.474% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | 42.558% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -55.505% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | 61.669% |
| Neutra Corp. | -233.46 Thousand USD | -420.129% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | 94.015% |
| PureTech Health plc | -65.69 Million USD | 98.152% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | 94.29% |
| IXICO plc | -1.17 Million USD | -3.083% |
| IntelGenx Technologies Corp. | -9.92 Million USD | 87.768% |
| Gelesis Holdings, Inc. | -57.12 Million USD | 97.874% |
| CSL Limited | 2.64 Billion USD | 100.046% |
| Cellectis S.A. | -103.17 Million USD | 98.823% |